Mutation of Cys105 inhibits dimerization of p12CDK2-AP1 and its growth suppressor effect
Yong Kim1, Hiroe Ohyama, Vipel Patel
1School of Dentistry and Dental Research Institute, UCLA, Los Angeles, California 90095, USA.
Abstract:
p12(CDK2-AP1) (p12) is a CDK2-associated protein that negatively regulates its kinase activity. Growth arrest of normal diploid cells by contact inhibition resulted in an induction of p27(kip1) and reduction of CDK2 levels. Interestingly, we observed concomitantly in growth-arrested cells, there was a reduction of nuclear p12 and the appearance of a nuclear 25-kDa molecule (p25) recognized by anti-p12 polyclonal antibody. Biochemical analysis showed that bacterial His-tagged p12 could be converted into a dimeric p25 in a reducing agent-dependent manner, and mutating the only cysteine residue of p12 (Cys(105) --> Ala(105)) abolished the dimerization. Transient transfection of wild type p12 into U2OS cells showed a reducing agent-sensitive dimerization that was also abolished by the C105A mutation. Furthermore, reduction of p12 expression by a short interfering RNA resulted in a parallel reduction of p25. These data supports the possibility that p25 is a homodimeric form of p12 through the cysteine residue. More interestingly, transient transfection of p12 (C105A) into the normal diploid lung fibroblast CCD18LU cells resulted in a reduction of the growth-inhibitory effect of p12 and abolished the inhibitory effect of p12 on CDK2 kinase activity. In addition, we found that the C105A mutation did not alter nuclear localization of p12, but it prevented association with CDK2. Taken together, our data suggest that p12 forms a nuclear homodimers in contact inhibited normal diploid cells and dimerization of p12 is a necessary process for the growth inhibition effect by p12.
Insights
p12 (CDK2-associated protein 1) forms nuclear dimers essential for growth inhibition. This dimerization, dependent on cysteine 105, is crucial for p12
Area of Science:
- Cell cycle regulation
- Protein dimerization
- Molecular biology
Background:
- p12 (CDK2-associated protein 1) negatively regulates CDK2 kinase activity.
- Contact inhibition in normal diploid cells leads to p27(kip1) induction and reduced CDK2 levels.
- A nuclear 25-kDa molecule (p25), recognized by anti-p12 antibody, appears in growth-arrested cells.
Purpose of the Study:
- To investigate the nature of the nuclear p25 molecule and its relationship to p12.
- To determine the role of p12 dimerization in its growth-inhibitory function.
- To elucidate the mechanism by which p12 affects CDK2 kinase activity.
Main Methods:
- Biochemical analysis of His-tagged p12 and its conversion to p25.
- Site-directed mutagenesis of the p12 cysteine residue (Cys105).
- Transient transfection studies in U2OS and CCD18LU cells.
- Short interfering RNA (siRNA) for p12 knockdown.
Main Results:
- p25 is a homodimeric form of p12, dependent on a reducing agent and the Cys105 residue.
- Mutation of Cys105 (C105A) abolished p12 dimerization and its growth-inhibitory effect.
- The C105A mutation prevented p12 association with CDK2 without affecting nuclear localization.
- siRNA-mediated reduction of p12 expression reduced p25 levels.
Conclusions:
- p12 forms nuclear homodimers in contact-inhibited normal diploid cells.
- Dimerization of p12, mediated by Cys105, is essential for its growth inhibition.
- p12 dimerization is required for its inhibitory effect on CDK2 kinase activity.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Abnormal Proliferation
Anaphase Promoting Complex
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle


